PwC & Arnold & Porter LLP- 340b Webinar
March 04, 2014 |
|
PwC & Arnold & Porter LLP- 340b Webinar |
Tuesday, March 04, 2014 at 12:00 PM Eastern Standard Time
You are invited to join PwC's Pharmaceutical and Life Sciences Industry Group and Arnold and Porter LLP's FDA and Healthcare practice for a webinar to discuss 340B, taking place on March 04, 2014 at 12:00 PM EST.
The 340B discount drug program has increasingly become a hot topic both for providers/covered entities, as well as pharmaceutical manufacturers. Heightened scrutiny from the government, coupled with the proliferation of contract pharmacies as well as the expansion of the program under the Affordable Care Act (ACA) has led this to be an area of focus both for manufacturers and for covered entities.
During this webinar, PwC and Arnold & Porter will share their client experiences and related insights on 340B from a manufacturer and legal point of view. This will include:
- An overview on the current 340B climate
- Key compliance Issues
- Double dipping
- Product diversion
- Proposed 340B audit approach
1.0 hour of MCLE credit pending
Note: If you are an attorney who is interested in CLE credit for this program, please list your state and bar number. CLE credit is pending and is not guaranteed.
|
To login for the webcast, please enter the required fields below. |
|
|
|